DexCom Launches Advanced OTC Glucose Biosensor in US Market nextdigitalhealth.com

A leading medical technology company focusing on continuous glucose monitoring (CGM) technology, DexCom, has launched the first ever over-the-counter (OTC) glucose biosensor in the US market.

Known as Stelo, the wearable allows users to monitor glucose levels in real-time via a smartphone app, eliminating the need for a traditional invasive fingerstick.